GH vs. IDXX: Guardant Health vs. IDEXX Laboratories Stock Comparison
How do Guardant Health (GH) and IDEXX Laboratories (IDXX) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Guardant Health (GH) and IDEXX Laboratories (IDXX) both fall under the Health Care Equipment & Services industry group, but GH is classified in Health Care Providers & Services while IDXX is classified in Health Care Equipment & Supplies.
| Profile Item | GH | IDXX |
|---|---|---|
| Name | Guardant Health, Inc. | IDEXX Laboratories, Inc. |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Providers & Services | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Services | Health Care Equipment |
| Market Capitalization | 20.41 billion USD | 53.26 billion USD |
| Currency | USD | USD |
| Exchange | Nasdaq | Nasdaq |
| Listing Date | October 4, 2018 | June 21, 1991 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | GH | IDXX |
|---|---|---|
| Total Return (1Y) | 66.53% | -1.84% |
| Total Return (3Y, Annualized) | 92.76% | 18.42% |
| Total Return (5Y, Annualized) | 8.36% | 2.02% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | GH | IDXX |
|---|---|---|
| Volatility (1Y, Annualized) | 53.23% | 37.02% |
| Beta (5Y) | 1.69 | 1.44 |
| Max Drawdown (5Y) | -85.09% | -50.91% |
| Avg. Volume (3M) | 1.97M | 564.80K |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | GH | IDXX |
|---|---|---|
| Sharpe Ratio (1Y) | 1.17 | -0.17 |
| Sortino Ratio (1Y) | 1.84 | -0.28 |
Profitability
ROE (TTM)
Capital efficiency shows on one side only: IDEXX Laboratories (IDXX) earns 68.93% on shareholders’ equity, ranked against its industry; Guardant Health (GH) has no ROE this period.
GH
Health Care Equipment & Services industry group
--
- Max
- 47.61%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
- GH
- --
IDXX
Health Care Equipment & Services industry group
68.93%
- IDXX
- 68.93%
- Max
- 47.61%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
Guardant Health (GH) reports a negative net margin of -37.93%, usually indicating a net loss over the period. Meanwhile IDEXX Laboratories (IDXX) reports 25.36%, ranking against industry peers normally.
GH
Health Care Equipment & Services industry group
-37.93%
- Max
- 29.35%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
- GH
- -37.93%
IDXX
Health Care Equipment & Services industry group
25.36%
- Max
- 29.35%
- IDXX
- 25.36%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
Guardant Health (GH) reports a negative operating margin of -37.06%, usually indicating that operating costs exceeded revenue at the operating-income line. Meanwhile IDEXX Laboratories (IDXX) reports 33.14%, ranking against industry peers normally.
GH
Health Care Equipment & Services industry group
-37.06%
- Max
- 35.43%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
- GH
- -37.06%
IDXX
Health Care Equipment & Services industry group
33.14%
- Max
- 35.43%
- IDXX
- 33.14%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | GH | IDXX |
|---|---|---|
| ROE (TTM) | -- | 68.93% |
| ROA (TTM) | -19.92% | 26.70% |
| Net Margin (TTM) | -37.93% | 25.36% |
| Operating Margin (TTM) | -37.06% | 33.14% |
| Gross Margin (TTM) | 65.19% | 62.72% |
Growth
Revenue Growth
Guardant Health (GH) at 32.88% sits in the top revenue growth quartile, while IDEXX Laboratories (IDXX) at 10.42% is closer to the peer norm — faster top-line expansion for GH.
EPS Growth
Only one side can be read here: IDEXX Laboratories (IDXX) reports EPS growth of 22.59%, ranked against its industry; Guardant Health (GH) has no EPS growth figure this period.
Growth Metrics
| Metric | GH | IDXX |
|---|---|---|
| Revenue Growth (YoY) | 32.88% | 10.42% |
| Revenue Growth (3Y CAGR) | 29.75% | 8.52% |
| EPS Growth (YoY) | -- | 22.59% |
| EPS Growth (3Y CAGR) | -- | 17.66% |
Financial Strength
Current Ratio (MRQ)
Guardant Health (GH) at 3.60 keeps current ratio within its industry’s typical mid-range, while IDEXX Laboratories (IDXX) at 1.19 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for IDXX.
GH
Health Care Equipment & Services industry group
3.60
- Max
- 7.59
- Q3
- 4.00
- GH
- 3.60
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
IDXX
Health Care Equipment & Services industry group
1.19
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- IDXX
- 1.19
- Min
- 0.30
Debt / Equity (MRQ)
Only one side’s leverage can be read here: IDEXX Laboratories (IDXX) carries debt-to-equity ratio of 0.52 against its industry range, while Guardant Health (GH) reports no figure this period.
GH
Health Care Equipment & Services industry group
--
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
- GH
- --
IDXX
Health Care Equipment & Services industry group
0.52
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- IDXX
- 0.52
- Q1
- 0.16
- Min
- 0.00
Financial Strength Metrics
| Metric | GH | IDXX |
|---|---|---|
| Current Ratio (MRQ) | 3.60 | 1.19 |
| Debt / Equity (MRQ) | -- | 0.52 |
| Net Debt / EBITDA | -- | 0.46 |
Dividends
Dividend Yield (TTM)
Neither Guardant Health (GH) nor IDEXX Laboratories (IDXX) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
GH
Health Care Equipment & Services industry group
0.00%
- GH
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
IDXX
Health Care Equipment & Services industry group
0.00%
- IDXX
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Neither Guardant Health (GH) nor IDEXX Laboratories (IDXX) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
GH
Health Care Equipment & Services industry group
0.00%
- GH
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
IDXX
Health Care Equipment & Services industry group
0.00%
- IDXX
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | GH | IDXX |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
| Dividend Payout Ratio (TTM) | 0.00% | 0.00% |
Valuation
P/E Ratio (TTM)
An earnings multiple is available for just one side: IDEXX Laboratories (IDXX) trades at 45.56 times trailing earnings, ranked against its peers, while Guardant Health (GH) has no P/E ratio this period.
GH
Health Care Equipment & Services industry group
--
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
- GH
- --
IDXX
Health Care Equipment & Services industry group
45.56
- Max
- 80.41
- Q3
- 47.62
- IDXX
- 45.56
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
Investors are paying well above the peer range per dollar of sales for both Guardant Health (GH) at 15.96 and IDEXX Laboratories (IDXX) at 11.42 — each P/S ratio clears its industry’s benchmark range.
GH
Health Care Equipment & Services industry group
15.96
- GH
- 15.96
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
IDXX
Health Care Equipment & Services industry group
11.42
- IDXX
- 11.42
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
Guardant Health (GH) reports a negative P/B ratio of -73.67, meaning negative book equity — the multiple itself is not meaningful for valuation. Meanwhile IDEXX Laboratories (IDXX) reports 28.50, ranking against industry peers normally.
GH
Health Care Equipment & Services industry group
-73.67
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
- GH
- -73.67
IDXX
Health Care Equipment & Services industry group
28.50
- IDXX
- 28.50
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | GH | IDXX |
|---|---|---|
| P/E Ratio (TTM) | -- | 45.56 |
| P/S Ratio (TTM) | 15.96 | 11.42 |
| P/B Ratio (MRQ) | -73.67 | 28.50 |
| Free Cash Flow Yield (TTM) | -0.30% | 2.00% |